Literature DB >> 10832104

Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.

E V Nagy1, J Toth, I Kaldi, J Damjanovich, E Mezosi, A Lenkey, L Toth, J Szabo, Z Karanyi, A Leovey.   

Abstract

BACKGROUND: Diplopia identifies patients with eye muscle involvement in Graves' ophthalmopathy (GO).
OBJECTIVE: To identify clinical parameters that could eliminate the need for magnetic resonance imaging (MRI) to assess the activity of inflammation in the eye muscles of GO patients with diplopia.
METHODS: In 43 patients with GO with recently developed diplopia, orbital ultrasound and MRI were performed. Muscle diameters and MRI T2 relaxation times were measured, and the amount of orbital connective tissue was calculated from MRI scans and compared with ultrasound readings, diplopia grades, degree of protrusion, ocular pressure, tear production, antibody levels and hormonal parameters of thyroid function.
RESULTS: No correlation was found between diameters of 233 extraocular muscles measured by MRI and by ultrasound. For each of the four muscles, there was a diameter above which ultrasound was always unreliable. MRI data were used in further analysis. Of the muscles examined, the inferior rectuses were the most frequently enlarged - at least one, in 93% of cases. Medial, lateral and superior rectuses were enlarged in 59%, 37% and 34% of the orbits respectively. The pattern of muscle involvement of the two orbits tended to be symmetric (r=0.49, P=0.003), particularly for the medial rectuses (r=0.90, P=0.000). Proptosis correlated with the sum of the muscle diameters for a given eye (right eye: r=0.54, P=0.003; left eye: r=0.57, P=0.001), but it failed to correlate with the amount of orbital connective tissue. In 53% of the patients, normal T2 relaxation times were found in all eight muscles. There was only a weak correlation between muscle thickness and T2 relaxation time (r=0.49, P=0.003), indicating that muscle enlargement alone is not a sign of disease activity. The severity of diplopia was independent of T2 relaxation time. The amount of orbital connective tissue showed a negative correlation with the greatest T2 relaxation time for a given eye (r= -0.52, P=0.004); this suggests that disease types exist that have predominant muscle involvement and predominant connective tissue expansion. No correlation between connective tissue expansion and proptosis, diplopia grade, muscle thickness or disease duration was found - that is, connective tissue expansion is not a major factor in diplopia. Both muscle and connective tissue findings were independent of thyroid function.
CONCLUSION: Ultrasound and MRI eye muscle diameter readings do not correlate, because of the inherent inaccuracy of orbital ultrasound. Muscle enlargement alone does not mean oedematous swelling and active disease. Neither ultrasound, nor any combination of 11 clinical and laboratory parameters provided the degree of information on muscles and connective tissue that was obtainable by MRI. In unclear cases of recently developed diplopia, before orbital decompression surgery, in the case of treatment failure or if, for any other reason, imaging is needed in GO, MRI is the method of choice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10832104     DOI: 10.1530/eje.0.1420591

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  23 in total

1.  Usefulness of the ratio of orbital fat to total orbit area in mild-to-moderate thyroid-associated ophthalmopathy.

Authors:  H C Kim; S W Yoon; H Lew
Journal:  Br J Radiol       Date:  2015-07-07       Impact factor: 3.039

2.  Update on advanced imaging options for thyroid-associated orbitopathy.

Authors:  Michael P Rabinowitz; Jacqueline R Carrasco
Journal:  Saudi J Ophthalmol       Date:  2012-10

3.  A new MRI method for the quantitative evaluation of extraocular muscle size in thyroid ophthalmopathy.

Authors:  K Aydin; K Güven; S Sencer; A Cikim; N Gül; O Minareci
Journal:  Neuroradiology       Date:  2003-02-19       Impact factor: 2.804

4.  Clinical Signs and Intraocular Pressure Changes in Patients with Orbitozygomatic Complex Fractures.

Authors:  Olasunkanmi F Kuye; Olawunmi A Fatusi; Folusho J Owotade; Samuel O Olateju; Oluwatoyin H Onakpoya
Journal:  J Maxillofac Oral Surg       Date:  2019-10-23

5.  Diagnostic accuracy of short-time inversion recovery sequence in Graves' Ophthalmopathy before and after prednisone treatment.

Authors:  Fabio Tortora; Mariaevelina Prudente; Mario Cirillo; Andrea Elefante; Maria Paola Belfiore; Francesco Romano; Salvatore Cappabianca; Carlo Carella; Sossio Cirillo
Journal:  Neuroradiology       Date:  2014-02-27       Impact factor: 2.804

6.  Disease activity in Graves' ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score.

Authors:  Fabio Tortora; Mario Cirillo; Marco Ferrara; Maria Paola Belfiore; Carlo Carella; Ferdinando Caranci; Sossio Cirillo
Journal:  Neuroradiol J       Date:  2013-11-07

7.  Analysis of the effect of repair materials for orbital blowout fracture on complications.

Authors:  Qi-Hua Xu; Jin-Hai Yu; Yao-Hua Wang; An-An Wang; Hong-Fei Liao
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

Review 8.  Recent developments in Graves' ophthalmopathy imaging.

Authors:  G J Kahaly
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

9.  Clinical and Radiological Findings in Patients with Newly Diagnosed Graves' Ophthalmopathy.

Authors:  Yakup Cevik; Hande Taylan Sekeroglu; Burce Ozgen; Kadriye Erkan Turan; Ali Sefik Sanac
Journal:  Int J Endocrinol       Date:  2021-04-30       Impact factor: 3.257

10.  Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy.

Authors:  Aditi Pandit; Abhay Gundgurthi; Sandeep Kharb; Karninder S Brar; M K Garg
Journal:  Indian J Endocrinol Metab       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.